KIMBERLY HESS: Open Payments
NPI 1831496181 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 15 payments from 10 companies in 2025. Trend: 2023 $463 · 2024 $1,032 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 5 | $114 |
| ARRAY BIOPHARMA INC | 2 | $39 |
| GENZYME CORPORATION | 1 | $29 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| SERVIER PHARMACEUTICALS LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| ABBVIE INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Eisai Inc. | 1 | $14 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
Products named: KEYTRUDA, XTANDI, SARCLISA, Fyarro, VENCLEXTA, BRAFTOVI, ZEJULA, Lenvima.
Industry payments across NC — which companies pay providers there.
